Annual Secretarial Compliance Report for the financial year ended March 31, 2026
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Windlas Biotech has filed its Annual Secretarial Compliance Report for FY 2025-26 under SEBI Regulation 24A. A practicing company secretary examined the company's compliance with various SEBI regulations including LODR, PIT, and Takeover regulations. The report confirms full compliance across all 13 checkpoints with no deviations, violations, or penalties. No actions were taken against the company or its promoters by SEBI or stock exchanges during the review period. The secretarial auditor found the company compliant with secretarial standards, maintained proper documentation, and fulfilled all disclosure requirements.
This clean compliance report is positive for shareholders as it confirms the company maintains good governance and regulatory adherence. No red flags were identified by the independent secretarial auditor.